Six-minute Walk Distance in Patients with Severe End-stage COPD: Association with Survival After Inpatient Pulmonary Rehabilitation
Overview
Authors
Affiliations
Purpose: To evaluate the relationship between the 6-minute walk distance (6MWD) and survival in a cohort of patients with severe end-stage chronic obstructive pulmonary disease (COPD) who received inpatient pulmonary rehabilitation (IPR) from 1995 to 2007.
Methods: We retrospectively analyzed 815 patients with severe end-stage COPD who received IPR. 6MWDs before and after IPR (pre-6MWD, post-6MWD) were compared to assess whether 6MWD was significantly changed after IPR. The Kaplan-Meier survival curves were constructed to show the relationship between survival and 6MWD. The age- and or comorbidities-adjusted Cox proportional hazard model was applied to assess association between the survival and the pre-6MWD, post-6MWD, or difference in 6MWD from the pre-6MWD to post-6MWD (Delta6MWD).
Results: Baseline demographics demonstrated a median age 74.0 years, mostly women (60.1%), and white (89.9%) patients with significant comorbid diseases who were most recently hospitalized in acute care facilities (95.1%). IPR significantly increased the 6MWD (mean distance change: 86.4 m; 95% confidence interval [CI], 81.5-91.3 m). Pre-6MWD was not significantly associated with survival. However, post-6MWD was significantly associated with age- and comorbidity-adjusted survival (post-6MWD hazard ratio = 1.336; 95% CI, 1.232-1.449 [post-6MWD x m relative to post-6MWD 2x m]), and Delta6MWD was also significantly associated with age-, comorbidities-, and pre-6MWD-adjusted survival (Delta6MWD hazard ratio = 1.337; 95% CI, 1.227-1.457 [Delta6MWD x m relative to Delta6MWD 2x m]).
Conclusions: In patients with severe end-stage COPD, IPR significantly improved 6MWD, and the post-6MWD and Delta6MWD were positively associated with the length of survival.
Spielmanns M, Buelow M, Pekacka-Egli A, Cecon M, Spielmanns S, Windisch W Microorganisms. 2021; 9(12).
PMID: 34946054 PMC: 8708417. DOI: 10.3390/microorganisms9122452.
Okamoto J, Furukawa Y, Kobinata N, Yoshikawa H, Araki F, Yagyu A J Phys Ther Sci. 2021; 33(10):779-783.
PMID: 34658524 PMC: 8516601. DOI: 10.1589/jpts.33.779.
Detection of Walk Tests in Free-Living Activities Using a Wrist-Worn Device.
Sokas D, Paliakaite B, Rapalis A, Marozas V, Bailon R, Petrenas A Front Physiol. 2021; 12:706545.
PMID: 34456748 PMC: 8397518. DOI: 10.3389/fphys.2021.706545.
Stability and Predictors of Poor 6-min Walking Test Performance over 2 Years in Patients with COPD.
Sanchez-Martinez M, Bernabeu-Mora R, Martinez-Gonzalez M, Gacto-Sanchez M, Martin San Agustin R, Medina-Mirapeix F J Clin Med. 2020; 9(4).
PMID: 32325637 PMC: 7231211. DOI: 10.3390/jcm9041155.
Timofte I, Tonelli A, Diaz-Abad M, Verceles A, Ladikos N, Iacono A Monaldi Arch Chest Dis. 2020; 90(1).
PMID: 32072801 PMC: 7905842. DOI: 10.4081/monaldi.2020.1186.